Cinctive Capital Management LP Boosts Stock Holdings in Encompass Health Co. (NYSE:EHC)

Cinctive Capital Management LP lifted its holdings in Encompass Health Co. (NYSE:EHC) by 143.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 93,312 shares of the company’s stock after purchasing an additional 54,931 shares during the period. Cinctive Capital Management LP’s holdings in Encompass Health were worth $8,617,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. MassMutual Private Wealth & Trust FSB increased its holdings in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after acquiring an additional 137 shares during the period. CBIZ Investment Advisory Services LLC boosted its holdings in shares of Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after buying an additional 127 shares in the last quarter. Tompkins Financial Corp purchased a new position in shares of Encompass Health in the 4th quarter worth approximately $46,000. V Square Quantitative Management LLC raised its stake in shares of Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after acquiring an additional 177 shares in the last quarter. Finally, Morse Asset Management Inc acquired a new stake in Encompass Health in the third quarter valued at approximately $68,000. 97.25% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on EHC. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. KeyCorp boosted their price target on Encompass Health from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Monday, February 10th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. Finally, Barclays increased their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, Encompass Health has an average rating of “Buy” and a consensus target price of $107.67.

Encompass Health Stock Down 0.0 %

Shares of NYSE EHC opened at $101.27 on Wednesday. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. Encompass Health Co. has a 52-week low of $78.53 and a 52-week high of $104.55. The firm has a market cap of $10.20 billion, a price-to-earnings ratio of 22.71, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The company’s 50-day simple moving average is $98.92 and its 200-day simple moving average is $97.58.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Equities analysts predict that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s payout ratio is presently 15.25%.

Insider Activity at Encompass Health

In other news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.10% of the stock is currently owned by insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.